254 related articles for article (PubMed ID: 27904778)
1. Long non-coding RNA CCAT2 promotes gastric cancer proliferation and invasion by regulating the E-cadherin and LATS2.
Wang YJ; Liu JZ; Lv P; Dang Y; Gao JY; Wang Y
Am J Cancer Res; 2016; 6(11):2651-2660. PubMed ID: 27904778
[TBL] [Abstract][Full Text] [Related]
2. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
Zheng J; Zhao S; He X; Zheng Z; Bai W; Duan Y; Cheng S; Wang J; Liu X; Zhang G
Biochem Biophys Res Commun; 2016 Nov; 480(4):508-514. PubMed ID: 27558961
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
Deng X; Zhao Y; Wu X; Song G
Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA CCAT2 is associated with poor prognosis in hepatocellular carcinoma and promotes tumor metastasis by regulating Snail2-mediated epithelial-mesenchymal transition.
Xu Y; Wang B; Zhang F; Wang A; Du X; Hu P; Zhu Y; Fang Z
Onco Targets Ther; 2017; 10():1191-1198. PubMed ID: 28280353
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition.
Xu Y; Yao Y; Qin W; Zhong X; Jiang X; Cui Y
Biomed Pharmacother; 2018 Mar; 99():121-127. PubMed ID: 29329034
[TBL] [Abstract][Full Text] [Related]
7. High expression of long non-coding RNA CCAT2 indicates poor prognosis of gastric cancer and promotes cell proliferation and invasion.
Wu SW; Hao YP; Qiu JH; Zhang DB; Yu CG; Li WH
Minerva Med; 2017 Aug; 108(4):317-323. PubMed ID: 28248065
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH
Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774
[TBL] [Abstract][Full Text] [Related]
9. LncRNA CCAT2 promoted osteosarcoma cell proliferation and invasion.
Yan L; Wu X; Yin X; Du F; Liu Y; Ding X
J Cell Mol Med; 2018 May; 22(5):2592-2599. PubMed ID: 29502343
[TBL] [Abstract][Full Text] [Related]
10. LncRNA CCAT2 promotes malignant progression of metastatic gastric cancer through regulating CD44 alternative splicing.
Deng H; Gao J; Cao B; Qiu Z; Li T; Zhao R; Li H; Wei B
Cell Oncol (Dordr); 2023 Dec; 46(6):1675-1690. PubMed ID: 37354353
[TBL] [Abstract][Full Text] [Related]
11. Silencing of Long Non-Coding RNA Colon Cancer-Associated Transcript 2 Inhibits the Growth and Metastasis of Gastric Cancer Through Blocking mTOR Signaling.
Lin S; Wang H; Yang W; Wang A; Geng C
Onco Targets Ther; 2020; 13():337-349. PubMed ID: 32021279
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA LINC00673 epigenetically suppresses KLF4 by interacting with EZH2 and DNMT1 in gastric cancer.
Ba MC; Long H; Cui SZ; Gong YF; Yan ZF; Wu YB; Tu YN
Oncotarget; 2017 Nov; 8(56):95542-95553. PubMed ID: 29221147
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition.
Liu J; Lu C; Xiao M; Jiang F; Qu L; Ni R
Biomed Pharmacother; 2017 May; 89():857-863. PubMed ID: 28282787
[TBL] [Abstract][Full Text] [Related]
14. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
He R; Zhang FH; Shen N
Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients.
Chen X; Liu L; Zhu W
Int J Clin Exp Pathol; 2015; 8(10):13261-6. PubMed ID: 26722527
[TBL] [Abstract][Full Text] [Related]
16. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.
Fan Y; Wang YF; Su HF; Fang N; Zou C; Li WF; Fei ZH
J Hematol Oncol; 2016 Jul; 9(1):57. PubMed ID: 27439973
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p.
Yan K; Tian J; Shi W; Xia H; Zhu Y
Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446
[TBL] [Abstract][Full Text] [Related]
20. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
Huang S; Qing C; Huang Z; Zhu Y
Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
